Can primary immunodeficiencies help  to provide insights into infectious risks  of therapeutic antibodies?
Maródi
László
L
Department of Infectious and Pediatric Immunology, University of Debrecen Medical and Health Science Center, Debrecen, Hungary. lmarodi@dote.hu
Casanova
Jean-Laurent
JL
D000911:Antibodies, Monoclonal / Q000009:adverse effects*; D018951:Antigens, CD20 / Q000276:immunology; D001424:Bacterial Infections / Q000209:etiology*; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000150:complications*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D018951:Antigens, CD20; D014409:Tumor Necrosis Factor-alpha